EXELIXIS, INC.
Income flow
Annual
EXEL 10-K Income StatementPeriod 2026-01-02Source 10-K
As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.
Revenue mix
2026-01-02 · 10-K · USD
By activity
- Product Gross$3.0B64.7%
- Cabometyx$2.1B45.4%
- License$214M4.6%
- Collaboration$197M4.2%
- Cometriq$9M0.2%
By geography
- United States$2.1B92.3%
- Europe$154M6.6%
- JP$26M1.1%
Capital & dividends
YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).247.8MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).213.6M
Valuation
Trailing PE 15.7 (2026-01-02)
Fiscal PE1
| Period | EPS | Close | PE |
|---|---|---|---|
| 2026-01-02 | 2.78 | 43.58 | 15.7 |
PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.